54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 11
00:58 UTC
|
CCHGY
Coca-Cola HBC
|
↓ Downgrade | firm only | Neutral | |
|
Aug 11
00:58 UTC
|
CC
Chemours
|
↓ Downgrade | Joshua Spector ★★★☆☆ #1604 | Buy→ Neutral | $18.00 |
|
Aug 11
00:58 UTC
|
BWMN
Bowman Consulting Group
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Aug 11
00:58 UTC
|
BLFS
BioLife Solutions
|
↓ Downgrade | Robert Wasserman ★★★☆☆ #1807 | Buy→ Hold | |
|
Aug 11
00:58 UTC
|
ATS
ATS
|
↓ Downgrade | firm only | Buy→ Hold | |
|
Aug 11
00:58 UTC
|
ATS
ATS
|
↓ Downgrade | firm only | Buy→ Hold | C$49.00→ C$33.00-32.7% |
|
Aug 11
00:58 UTC
|
ARKO
ARKO
|
↓ Downgrade | Bobby Griffin ★★★★☆ #667 | Strong-Buy→ Outperform | $8.00→ $7.00-12.5% |
|
Aug 11
00:58 UTC
|
AMRZ
Amrize
|
↓ Downgrade | Anthony Codling ★★★☆☆ #1322 | Sec→ r Perform ➝ Underperform | $60.00→ $48.00-20.0% |
|
Aug 11
00:58 UTC
|
ACH
Accendra Health
|
↓ Downgrade | Daniel Grosslight ★★★★☆ #919 | Buy→ Neutral | |
|
Aug 11
00:58 UTC
|
AAPL
Apple
|
↓ Downgrade | Edison Lee ★★☆☆☆ #2869 | Buy→ Underperform | $285.56→ $263.66-7.7% |
|
Aug 11
00:58 UTC
|
UMC
United Microelectronics
|
↑ Upgrade | firm only | Neutral→ Buy | |
|
Aug 11
00:58 UTC
|
SNDK
Sandisk
|
↑ Upgrade | Jim Kelleher ★★★☆☆ #1142 | Hold→ Buy | |
|
Aug 11
00:58 UTC
|
SION
Sionna Therapeutics
|
↑ Upgrade | firm only | Underperform→ Sector Perform | $5.00 |
|
Aug 11
00:58 UTC
|
SEZL
Sezzle
|
↑ Upgrade | Moshe Orenbuch ★★★★☆ #628 | Hold→ Buy | $165.00 |
|
Aug 11
00:58 UTC
|
PTGX
Protagonist Therapeutics
|
↑ Upgrade | firm only | Buy | |
|
Aug 11
00:58 UTC
|
PTGX
Protagonist Therapeutics
|
↑ Upgrade | Richard Law not yet tracked | Neutral→ Buy | $110.00→ $186.00+69.1% |
|
Aug 11
00:58 UTC
|
P
Everpure
|
↑ Upgrade | Mehdi Hosseini ★★★☆☆ #1838 | Neutral→ Positive | $85.00→ $120.00+41.2% |
|
Aug 11
00:58 UTC
|
P
Everpure
|
↑ Upgrade | Benjamin Swinburne ★★★☆☆ #1613 | Equal Weight→ Overweight | $87.00→ $108.00+24.1% |
|
Aug 11
00:58 UTC
|
NTAP
NetApp
|
↑ Upgrade | Erik Woodring ★★★☆☆ #1448 | Underweight→ Equal Weight | $137.00→ $173.00+26.3% |
|
Aug 11
00:58 UTC
|
LXU
Lsb Industries
|
↑ Upgrade | Andrew D. Wong not yet tracked | Sec→ r Perform ➝ Outperform | $13.00 |
|
Aug 11
00:58 UTC
|
LECO
Lincoln Electric
|
↑ Upgrade | Angel Castillo ★★★☆☆ #2108 | Underweight→ Equal Weight | $257.00→ $283.00+10.1% |
|
Aug 11
00:58 UTC
|
JHX
James Hardie Industries
|
↑ Upgrade | Matthew Bouley ★★★★☆ #969 | Equal Weight→ Overweight | $26.00→ $35.00+34.6% |
|
Aug 11
00:58 UTC
|
HPE
Hewlett Packard Enterprise
|
↑ Upgrade | Meta Marshall ★★★☆☆ #1397 | Equal Weight→ Overweight | $71.00→ $69.00-2.8% |
|
Aug 11
00:58 UTC
|
FCFS
FirstCash
|
↑ Upgrade | Anthony Chukumba ★★☆☆☆ #2454 | Hold→ Buy | $255.00 |
|
Aug 11
00:58 UTC
|
EVH
Evolent Health
|
↑ Upgrade | Daniel Grosslight ★★★★☆ #919 | Neutral→ Buy | |
|
Aug 11
00:58 UTC
|
DKS
DICK'S Sporting Goods
|
↑ Upgrade | firm only | Buy→ Positive | |
|
Aug 11
00:58 UTC
|
DKS
DICK'S Sporting Goods
|
↑ Upgrade | Ike Boruchow ★★★★☆ #775 | Equal Weight→ Overweight | $220.00→ $240.00+9.1% |
|
Aug 11
00:58 UTC
|
BTO
B2Gold
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | C$6.50→ C$11.00+69.2% |
|
Aug 11
00:58 UTC
|
BTO
B2Gold
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Sector Outperform | C$10.00 |
|
Aug 11
00:58 UTC
|
BTO
B2Gold
|
↑ Upgrade | firm only | Hold→ Buy | C$6.00→ C$8.50+41.7% |
|
Aug 11
00:58 UTC
|
BTG
B2Gold
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Sector Outperform | |
|
Aug 11
00:58 UTC
|
BTG
B2Gold
|
↑ Upgrade | firm only | Neutral→ Outperform | |
|
Aug 11
00:58 UTC
|
AGL
Agilon Health
|
↑ Upgrade | Daniel Grosslight ★★★★☆ #919 | Sell→ Neutral | |
|
Aug 10
23:58 UTC
|
MNDY
monday.com
|
↓ Downgrade | Thomas Blakey ★★★☆☆ #1444 | Overweight→ Neutral | $90.00 |
|
Aug 10
22:58 UTC
|
VREX
Varex Imaging
|
↓ Downgrade | firm only | Market Perform | |
|
Aug 10
22:58 UTC
|
MNDY
monday.com
|
↓ Downgrade | Thomas Blakey ★★★☆☆ #1444 | Overweight→ Neutral | |
|
Aug 10
22:58 UTC
|
ACH
Accendra Health
|
↓ Downgrade | Daniel Grosslight ★★★★☆ #919 | Buy→ Neutral | |
|
Aug 10
22:58 UTC
|
EVH
Evolent Health
|
↑ Upgrade | Daniel Grosslight ★★★★☆ #919 | Neutral→ Buy | |
|
Aug 10
22:58 UTC
|
AGL
Agilon Health
|
↑ Upgrade | Daniel Grosslight ★★★★☆ #919 | Sell→ Neutral | |
|
Aug 10
21:57 UTC
|
TRAX
First Tracks Biotherapeutics
|
◎ Target | Michael Yee ★★★☆☆ #1045 | Buy | $45.00→ $65.00+44.4% |
|
Aug 10
21:57 UTC
|
STLD
Steel Dynamics
|
◎ Target | Andrew Jones not yet tracked | Neutral | $165.00→ $276.00+67.3% |
|
Aug 10
21:57 UTC
|
SI
Shoulder Innovations
|
◎ Target | Patrick Wood ★★★☆☆ #2136 | Buy | $27.00→ $28.00+3.7% |
|
Aug 10
20:57 UTC
|
TWFG
TWFG
|
◎ Target | Brian Meredith ★★★★★ #229 | Buy | $30.00→ $34.00+13.3% |
|
Aug 10
20:57 UTC
|
PRIM
Primoris Services
|
◎ Target | Steven Fisher ★★☆☆☆ #2669 | Buy | $186.00→ $138.00-25.8% |
|
Aug 10
20:57 UTC
|
MTDR
Matador Resources
|
◎ Target | Peyton Dorne ★★★★☆ #672 | Neutral | $54.00→ $56.00+3.7% |
|
Aug 10
20:57 UTC
|
KMT
Kennametal
|
◎ Target | Steven Fisher ★★☆☆☆ #2669 | Neutral | $39.00→ $35.00-10.3% |
|
Aug 10
20:57 UTC
|
KMPR
Kemper
|
◎ Target | Brian Meredith ★★★★★ #229 | Buy | $44.00→ $43.00-2.3% |
|
Aug 10
20:57 UTC
|
KBR
KBR
|
◎ Target | Steven Fisher ★★☆☆☆ #2669 | Neutral | $36.00→ $41.00+13.9% |
|
Aug 10
20:57 UTC
|
J
Jacobs Solutions
|
◎ Target | Steven Fisher ★★☆☆☆ #2669 | Buy | $156.00→ $167.00+7.1% |
|
Aug 10
20:57 UTC
|
FLR
Fluor
|
◎ Target | Steven Fisher ★★☆☆☆ #2669 | Buy | $59.00→ $66.00+11.9% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.